Increased BM plasma level of soluble CD30 in AA

Figure S1. Representative FCM analyses showed the kinetics of cell surface expression of CD30 by CD3+CD8+ T cells and CD3+CD8- T cells after allogeneic stimulation. BM CD3+ T cells from healthy individuals and SAA patients were co-cultured with mitomycin C treated allogenetic mononuclear cells for a total of 7 days. Figure S2. CD30 positive T cells were mainly contained in the cell population with larger FSC and SSC. Representative FCM analyses showed the cell surface expression of CD30 by T cells at day 4 after allogeneic stimulation. Figure S3. CsA inhibited the expression of CD30 by allogeneic stimulated T cells. Representative FCM analyses showed the cell surface expression of CD30 by T cells at day 4 after allogeneic stimulation. Figure S4. Correlation of BM plasma sCD30 levels with baseline RET in SAA and VSAA patients (n=19). Table S1. Patients’ characteristics.